Inactivation of retrotransposon Tos17 (Chr.7) in rice cultivar Nipponbare through CRISPR/Cas9-mediated gene editing

利用 CRISPR/Cas9 介导的基因编辑技术使水稻品种日本晴中的逆转录转座子 Tos17(7 号染色体)失活

阅读:1

Abstract

Retrotransposons are mobile genetic elements capable of transposition via reverse transcription of RNA intermediates. Rice cultivar Nipponbare contains two nearly identical genomic copies of Tos17, an endogenous copia-like LTR retrotransposon, on chromosomes 7 (Tos17 (Chr.7)) and 10 (Tos17 (Chr.10)), respectively. Previous studies demonstrated that only Tos17 (Chr.7) is active in transposition during tissue culture. Tos17 (Chr.7) has been extensively used for insertional mutagenesis as a tool for functional analysis of rice genes. However, Tos17 (Chr.7) transposition might generate somaclonal mutagenesis with undesirable traits during rice transformation, which would affect the evaluation or application of transgenes. In this study, we generated a Tos17 (Chr.7) knockout mutant D873 by using CRISPR/Cas9 gene editing system. The gene-edited allele of Tos17 (Chr.7) in D873, designated as Tos17 (D873), has an 873-bp DNA deletion in the pol gene of Tos17 (Chr.7), which caused the deletion of the GAG-pre-integrase domain and the integrase core domain. Although the transcription of Tos17 (D873) was activated in D873 calli, no transposition of Tos17 (D873) was detected in the regenerated D873 plants. The results demonstrate that the GAG-pre-integrase domain and the integrase core domain are essential for Tos17 (Chr.7) transposition and the deletion of the two domains could be not complemented by other LTR retrotransposons in rice genome. As the Tos17 (Chr.7)-derived somaclonal mutagenesis is blocked in the D873 plants, the generation of the Tos17 (D873) allele will be helpful in production of transgenic rice plants for gene function study and genetic engineering. Similar approach can be used to inactivate other retrotransposons in crop breeding.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。